International Journal of Public Health

, Volume 59, Issue 3, pp 519–528 | Cite as

Practices and opinions regarding HPV vaccination among French general practitioners: evaluation through two cross-sectional studies in 2007 and 2010

  • Christine Lasset
  • Julie Kalecinski
  • Véronique Régnier
  • Giovanna Barone
  • Yann Leocmach
  • Philippe Vanhems
  • Franck Chauvin
  • Delphine Lutringer-Magnin
Original Article



To use both quantitative and qualitative methods to investigate the evolution of practices and opinions regarding human papillomavirus (HPV) vaccination among French general practitioners.


A cross-sectional study (self-questionnaires) was performed in 2007 and repeated in 2010 among 271 general practitioners. Semi-structured interviews were conducted on 27 voluntary participants by a sociologist and analyzed according to content analysis.


Acceptability of HPV vaccination had increased from 2007 to 2010 (79.9 vs. 87.1 %, respectively), just as the practice of HPV vaccination among 14-year-old girls (19.0 vs. 49.1 %, respectively). Though about 60 % reported complications associated with HPV vaccination, irrespective of year, the types of difficulties have varied: difficulties related to “questions asked by patients” had decreased, though concerns about side effects had remained stable. During interviews, difficulties related to “the reason for medical consultation” and “the target age” were often associated with addressing the issue of sexuality, especially when the parents were present.


Although the high level of acceptability of HPV vaccination among general practitioners, which increased from 2007 to 2010, there remain difficulties in addressing this practice.


HPV vaccination General practitioner Practice Opinion Attitude Evolution 


  1. Agius PA, Pitts MK, Smith AM, Mitchell A (2010) Human papillomavirus and cervical cancer: Gardasil vaccination status and knowledge amongst a nationally representative sample of Australian secondary school students. Vaccine 28:4416–4422PubMedCrossRefGoogle Scholar
  2. Brotherton JM, Fridman M, May CL, Chappell G, Saville AM, Gertig DM (2011) Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet 377:2085–2092PubMedCrossRefGoogle Scholar
  3. Creswell JW, Plano Clark VL (2007) Designing and conducting mixed methods research. Sage Publications, Thousand OaksGoogle Scholar
  4. Daley MF, Crane LA, Markowitz LE, Black SR, Beaty BL, Barrow J et al (2010) Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics 126:425–433PubMedCrossRefGoogle Scholar
  5. Darden PM, Thompson DM, Roberts JR, Hale JJ, Pope C, Naifeh M, et al. (2013) Reasons for not vaccinating adolescents: national immunization survey of teens, 2008–2010. Pediatrics 131:645–651Google Scholar
  6. De Carvalho NS, Teixeira LM, Pradel EM, Gabardo J, Joly C, Urbanetz AA (2009) Vaccinating against HPV: physicians’ and medical students’ point of view. Vaccine 27:2637–2640PubMedCrossRefGoogle Scholar
  7. Demarteau N, Detournay B, Tehard B, El Hasnaoui A, Standaert B (2011) A generally applicable cost-effectiveness model for the evaluation of vaccines against cervical cancer. Int J Public Health 56:153–162PubMedCentralPubMedCrossRefGoogle Scholar
  8. Donovan B, Franklin N, Guy R, Grulich AE, Regan DG, Ali H et al (2011) Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis 11:39–44PubMedCrossRefGoogle Scholar
  9. Dorleans F, Giambi C, Dematte L, Cotter S, Stefanoff P, Mereckiene J, et al. (2010) The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey. Euro Surv 15(47)Google Scholar
  10. European Centre for Disease prevention and Control (2012) ECDC guidance, introduction of HPV vaccines in European Union countries––an update. pp 19Google Scholar
  11. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2011) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917CrossRefGoogle Scholar
  12. Forster AS, Marlow LA, Wardle J, Stephenson J, Waller J (2010) Understanding adolescents’ intentions to have the HPV vaccine. Vaccine 28:1673–1676PubMedCrossRefGoogle Scholar
  13. Haesebaert J, Lutringer-Magnin D, Kalecinski J, Barone G, Jacquard AC, Régnier V et al (2012) French women’s knowledge of and attitudes towards cervical cancer prevention and the acceptability of HPV vaccination among those with 14–18 year old daughters: a quantitative–qualitative study. BMC Public Health 12:1034PubMedCentralPubMedCrossRefGoogle Scholar
  14. Haut Conseil de la santé publique (2011). Avis relatif au vaccin Gardasil® et à la stratégie de prévention globale des cancers du col de l’utérus à la vaccination contre les infections à papillomavirus humains des jeunes filles âgées de 14 à 23 ans (HPV vaccination recommendations from the « Haut Conseil de la santé publique » in France). Available: Accessed 22 February 2013
  15. Hopkins TG, Wood NJ, West RM, Darling JC (2009) UK health professionals’ attitudes and knowledge regarding Human Papillomavirus (HPV) vaccination: a West Yorkshire Study. J Paediatr Child Health 45:652–655PubMedCrossRefGoogle Scholar
  16. Institut de Veille Sanitaire (2012) Projection de l’incidence et de la mortalité par cancer en France en 2011: col de l’utérus. Available: Accessed 30 January 2013
  17. Jeannot E, Sudre P, Chastonay P (2012) HPV vaccination coverage within 3 years of program launching (2008–2011) at Geneva State, Switzerland. Int J Public Health 57:629–632PubMedCrossRefGoogle Scholar
  18. Jensen ME, Hartenbach E, McElroy JA, Faerber A, Havighurst T, Kim KM et al (2009) Brief report: measuring the attitudes of health care professionals in Dane County toward adolescent immunization with HPV vaccine. WMJ 108:203–205PubMedCentralPubMedGoogle Scholar
  19. Jim CC, Lee JW, Groom AV, Espey DK, Saraiya M, Holve S et al (2012) Human papillomavirus vaccination practices among providers in Indian health service, tribal and urban Indian healthcare facilities. J Womens Health 21:372–378CrossRefGoogle Scholar
  20. Kahn JA, Cooper HP, Vadaparampil ST, Pence BC, Weinberg AD, LoCoco SJ et al (2009) Human papillomavirus vaccine recommendations and agreement with mandated human papillomavirus vaccination for 11-to-12-year-old girls: a statewide survey of Texas physicians. Cancer Epidemiol Biomarkers Prev 18:2325–2332PubMedCrossRefGoogle Scholar
  21. Kempe A, Daley MF, McCauley MM, Crane LA, Suh CA, Kennedy AM et al (2011) Prevalence of parental concerns about childhood vaccines: the experience of primary care physicians. Am J Prev Med 40:548–555PubMedCrossRefGoogle Scholar
  22. Ko EM, Missmer S, Johnson NR (2010) Physician attitudes and practice toward human papillomavirus vaccination. J Low Genit Tract Dis 14:339–345PubMedCrossRefGoogle Scholar
  23. Krupp K, Marlow LA, Kielmann K, Doddaiah N, Mysore S, Reingold AL et al (2010) Factors associated with intention-to-recommend human papillomavirus vaccination among physicians in Mysore, India. J Adolesc Health 46:379–384PubMedCrossRefGoogle Scholar
  24. Leib S, Liberatos P, Edwards K (2011) Pediatricians’ experience with and response to parental vaccine safety concerns and vaccine refusals: a survey of Connecticut pediatricians. Public Health Rep 126(Suppl 2):13–23PubMedCentralPubMedGoogle Scholar
  25. Lu B, Kumar A, Castellsagué X, Giuliano AR (2011) Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review and meta-analysis. BMC Infect Dis 11:13PubMedCentralPubMedCrossRefGoogle Scholar
  26. Lutringer-Magnin D, Kalecinski J, Barone G, Leocmach Y, Regnier V, Jacquard AC et al (2011) Human papillomavirus (HPV) vaccination: perception and practice among French general practitioners in the year since licensing. Vaccine 29:5322–5328PubMedCrossRefGoogle Scholar
  27. Marlow LA, Wardle J, Forster AS, Waller J (2009) Ethnic differences in human papillomavirus awareness and vaccine acceptability. J Epidemiol Commun Health 63:1010–1015CrossRefGoogle Scholar
  28. McCave EL (2010) Influential factors in HPV vaccination uptake among providers in four states. J Commun Health 35:645–652CrossRefGoogle Scholar
  29. Miles MB, Huberman MA (2003) Analyse des données qualitatives. De Boeck, Bruxelles, p 2Google Scholar
  30. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV et al (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518–527PubMedCrossRefGoogle Scholar
  31. Pélissier G, Bastides F (2008) Vaccination anti-HPV dans le cadre de la prévention du cancer du col de l’utérus en médecine générale. Rev Prat 58:25–31PubMedGoogle Scholar
  32. Perkins RB, Clark JA (2012) What affects human papillomavirus vaccination rates? A qualitative analysis of providers’ perceptions. Womens Health Issues 22:e378–e379CrossRefGoogle Scholar
  33. Piana L, Noel G, Uters M, Laporte R, Minodier P (2009) Standpoint and practice concerning the human Papillomavirus vaccine among French family physicians. Med Mal Infect 39:789–797PubMedCrossRefGoogle Scholar
  34. Post RE, Carek PJ, Mainous Iii AG, Diaz VA, Johnson SP (2013) Factors affecting HPV vaccine use among recent family medicine residency graduates. Fam Med 45:90–94PubMedGoogle Scholar
  35. Remes P, Selestine V, Changalucha J, Ross DA, Wight D, de Sanjosé S et al (2012) A qualitative study of HPV vaccine acceptability among health workers, teachers, parents, female pupils, and religious leaders in northwest Tanzania. Vaccine 30:5363–5367PubMedCentralPubMedCrossRefGoogle Scholar
  36. Schnatz PF, Humphrey K, O’Sullivan DM (2010) Assessment of the perceptions and administration of the human papillomavirus vaccine. Low Genit Tract Dis 14:103–107CrossRefGoogle Scholar
  37. Trim K, Nagji N, Elit L, Roy K (2012) Parental knowledge, attitudes, and behaviours towards human papillomavirus vaccination for their children: a systematic review from 2001 to 2011. Obstet Gynecol Int 2012:921236PubMedCentralPubMedCrossRefGoogle Scholar
  38. Vadaparampil ST, Kahn JA, Salmon D, Lee JH, Quinn GP, Roetzheim R et al (2011) Missed clinical opportunities: provider recommendations for HPV vaccination for 11–12 years old girls are limited. Vaccine 29:8634–8641PubMedCentralPubMedCrossRefGoogle Scholar
  39. Wong LP (2011) Issues surrounding HPV vaccine delivery in a multi-ethnic country in Asia: the physician’s perspective. J Commun Health 36:14–22CrossRefGoogle Scholar
  40. Young JL, Bernheim RG, Korte JE, Stoler MH, Guterbock TM, Rice LW (2011) Human papillomavirus vaccination recommendation may be linked to reimbursement: a survey of Virginia family practitioners and gynecologists. J Pediatr Adolesc Gynecol 24:380–385PubMedCrossRefGoogle Scholar

Copyright information

© Swiss School of Public Health 2014

Authors and Affiliations

  • Christine Lasset
    • 1
    • 2
  • Julie Kalecinski
    • 3
  • Véronique Régnier
    • 3
  • Giovanna Barone
    • 1
  • Yann Leocmach
    • 4
  • Philippe Vanhems
    • 2
    • 5
  • Franck Chauvin
    • 3
  • Delphine Lutringer-Magnin
    • 1
    • 2
  1. 1.Département de santé publique, Centre Léon BérardUniversité Lyon 1, CNRS UMR 5558Lyon cedex 08France
  2. 2.Laboratoire de biométrie et biologie évolutiveUniversité Lyon 1VilleurbanneFrance
  3. 3.Institut de Cancérologie Lucien NeuwirthSaint-EtienneFrance
  4. 4.Sanofi Pasteur MSDLyonFrance
  5. 5.Département d’hygiène, épidémiologie et préventionHospices Civils de LyonLyonFrance

Personalised recommendations